We partner with investors and industrial leaders across the Chemicals & Advanced Materials sector to drive tangible results, blending deep technical expertise with sharp strategic thinking to unlock value across the entire ecosystem. From base chemicals to specialty formulations, from chemical intermediates to advanced polymers, from industrial to crop nutrition and protection, our expertise covers the full spectrum of the industry, combining deep market insight, operational rigor, and strategic vision. With over 300 transactions advised and $135Bn+ in deal value since 2017, 150 engagements realized every year for PE firms, portfolio companies, and corporates to enhance value, our teams are trusted by the world's leading funds and corporates to turn technical complexity into competitive advantage. We support corporates and corporate boards across all critical stages: growth strategies, operational transformations, buy- and sell-side due diligence, sustainability & decarbonation challenges, and net-zero strategies.

In today's consumer and patient-driven landscape, helping brands and investors to stay ahead of the curve. Our work spans Consumer Health and Consumer Goods ecosystems, covering branded products and private label — from OTC, medical devices, food supplements, specialized nutrition, sports nutrition, and dermocosmetics to consumer packaged goods across food & beverage, beauty, home, and lifestyle. We bring a unique blend of investor-minded thinking and operational precision to every engagement, whether it's scaling a high-growth brand or reshaping the go-to-market strategy of a consumer health portfolio. Our teams combine deep sector insight with hands-on experience in strategy, commercial due diligence, revenue growth strategy, go-to-market, digital acceleration, and target screening — with hundreds of successful projects delivered for global corporates and top-tier private equity firms.

Partnering with investors and corporates to unlock growth across the entire Pharmaceuticals and Medtech value chains, from upstream ingredients and device components to finished pharmaceutical and medtech products, encompassing B2B platforms, distribution models, and patient care pathways. Our expertise covers Pharma Services (CDMO, CRO and other Clinical Services), Specialty Pharma, Generics, and OTC, as well as all major medtech categories, including IVD, orthopedics, cardiovascular, and surgical devices. With close to 150 projects delivered annually for top-tier private equity firms and corporate clients, Advancy combines investor understanding with operational depth across every segment of the value chain. Our approach is specialized and hands-on, with expert senior leadership involved in each engagement to ensure technical rigor and actionable outcomes — grounded in deep scientific fluency and a wide network of experts in medical, R&D, commercial, and manufacturing functions.

Long-term competitive advantage is built at the intersection of strategic clarity and operational excellence. In a world of constant change — driven by shifting market dynamics, regulatory pressures, and technological disruption — we help industrial leaders and investors navigate complexity with confidence. Our strength lies in our deep sector focus: we serve the full industrial spectrum, from construction materials and packaging to semiconductors, mobility, business services, and energy transition — bringing a rare combination of strategic insight, hands-on experience, and real-world pragmatism. With a global presence and a track record of over 800 successful transactions, our teams work side by side with investors and leadership teams, crafting tailored strategies, guiding transformational deals, and implementing practical solutions that deliver measurable results — whether repositioning for growth, evaluating an acquisition, or building operational resilience.

The Life Sciences & Ingredients industries sit at the intersection of technological innovation, regulatory scrutiny, and evolving consumer and sustainability expectations. Whether in pharmaceuticals, nutrition, or agricultural inputs, companies and investors must navigate complex supply chains, specialized manufacturing processes, and shifting market dynamics. At Advancy, we combine deep scientific and industrial expertise with strategic analysis informed by real market dynamics and operational realities. We work with private equity sponsors, corporates, and management teams across the full investment and operational lifecycle, from commercial and operational due diligence to portfolio strategy, industrial competitiveness, pricing, and ESG transformation — with decades-long sector experience and a wide network of advisors within the Life Sciences and Ingredients industries.

In a world of shifting consumer expectations, omnichannel acceleration, and ESG imperatives, brands and operators must rethink how they create and capture value. We help retail, luxury, and entertainment leaders define where to play, why it matters, and how to win — combining strategic foresight with operational precision. From growth acceleration to strategic repositioning, we act as trusted advisors to executive teams and investors, bringing targeted expertise in AI, digital, and ESG applied where they create measurable value across customer and data centricity, brand desirability, supply chain performance, and omnichannel transformation. Across Retail & Luxury, we help brands and retailers transform their model by enhancing desirability, unifying their clients' vision and experience, boosting supply chain performance, and embedding sustainability across product strategy, sourcing, and operations. In Travel & Entertainment, we support operators from experiential venues to digital platforms in refining their strategic positioning, accelerating digital performance, and designing growth models anchored in user experience, brand engagement, and profitability.

Advancy supports investors and leadership teams across the full transaction lifecycle—from buy-side strategic due diligence and sell-side value articulation to post-merger integration and synergy realisation. Capabilities include buy-side strategic due diligence, sell-side value articulation and vendor due diligence, synergy assessment and value capture, post-merger integration (PMI) and 100-day planning, and ESG & regulatory readiness in transactions. The firm positions itself as a recognized leader in external growth for 8 years in a row, delivering end-to-end M&A advisory and value creation support to investors and corporate leadership teams.

Advancy helps leadership teams design operating models and governance structures that translate strategic ambition into operational performance. Capabilities include organizational assessment and benchmarking, operating model design and transformation, roles and decision rights definition, governance structure design, performance management and KPI frameworks, leadership alignment and change management, workforce planning and capability building, and culture diagnosis & transformation. The service combines diagnostic assessment with hands-on transformation execution, enabling organizations to align structure, systems, and culture with strategic priorities and operational excellence objectives.

Advancy helps leadership teams define and activate winning strategies by combining deep market insight with pragmatic, innovation-driven execution. Services span corporate strategy and portfolio reviews, business model and growth strategy, go-to-market and customer value proposition development, innovation strategy and new business incubation, international development and market entry, and strategic due diligence and competitive benchmarking. Demonstrated through case studies including growth strategy development in China and Asia for a leading aluminium producer targeting +40% growth with $500M investment, combining market entry strategy with portfolio expansion and innovation-driven execution.

Advancy partners with leadership teams to unlock full commercial potential through customer segmentation, omnichannel go-to-market strategy, pricing and revenue management, salesforce effectiveness, and brand positioning. Services include commercial due diligence, customer segmentation and value proposition development, omnichannel go-to-market strategy design, pricing & commercial efficiency optimization, salesforce effectiveness & performance steering, marketing mix optimization, and brand positioning & customer experience innovation. The integrated approach combines demand-side customer insights with supply-side commercial execution, enabling leadership teams to align commercial strategy with market opportunities and operational capabilities.

Advancy supports leadership teams, boards, and investors in navigating inflection points through tailored turnaround strategies and performance transformation programs combining rigorous diagnostics with senior-led execution. Services include strategic diagnostic & operational excellence assessments, cost optimization & efficiency gains programs, turnaround strategy development and execution, governance and performance steering, and carve-out, spin-off, and restructuring strategy support. Demonstrated expertise through case study on operational and development process improvement for a leading hospitality group across Brazil, Argentina, Peru and Chile, combining operational excellence with restructuring execution and performance transformation.